Last updated on August 2020

Duowell vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension


Brief description of study

This study is to evaluate effect and safety on central blood pressure with Duowell compared to telmisartan monotherapy in mild dyslipidemia patients with hypertension during 16 weeks.

Clinical Study Identifier: NCT03267329

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.